Skip to main content
Top
Published in: AIDS and Behavior 9/2018

01-09-2018 | Original Paper

Building the Case for Localized Approaches to HIV: Structural Conditions and Health System Capacity to Address the HIV/AIDS Epidemic in Six US Cities

Authors: D. Panagiotoglou, M. Olding, B. Enns, D. J. Feaster, C. del Rio, L. R. Metsch, R. M. Granich, S. A. Strathdee, B. D. L. Marshall, M. R. Golden, S. Shoptaw, B. R. Schackman, B. Nosyk, the Localized HIV Modeling Study Group

Published in: AIDS and Behavior | Issue 9/2018

Login to get access

Abstract

Since the discovery of the secondary preventive benefits of antiretroviral therapy, national and international governing bodies have called for countries to reach 90% diagnosis, ART engagement and viral suppression among people living with HIV/AIDS. The US HIV epidemic is dispersed primarily across large urban centers, each with different underlying epidemiological and structural features. We selected six US cities, including Atlanta, Baltimore, Los Angeles, Miami, New York, and Seattle, with the objective of demonstrating the breadth of epidemiological and structural differences affecting the HIV/AIDS response across the US. We synthesized current and publicly-available surveillance, legal statutes, entitlement and discretionary funding, and service location data for each city. The vast differences we observed in each domain reinforce disparities in access to HIV treatment and prevention, and necessitate targeted, localized strategies to optimize the limited resources available for each city’s HIV/AIDS response.
Appendix
Available only for authorised users
Literature
1.
go back to reference The HIV epidemic can be stopped. Nature. 2015;523(7559):127. The HIV epidemic can be stopped. Nature. 2015;523(7559):127.
2.
go back to reference Samji H, Cescon A, Hogg R, Modur S, Althoff K, Buchacz K, et al. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS ONE. 2013;8(12):e81355.CrossRefPubMedPubMedCentral Samji H, Cescon A, Hogg R, Modur S, Althoff K, Buchacz K, et al. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS ONE. 2013;8(12):e81355.CrossRefPubMedPubMedCentral
8.
go back to reference National HIV/AIDS strategy for United States. Washington, DC: The White Hourse Office of National AIDS Policy 2010 13 July 2010. National HIV/AIDS strategy for United States. Washington, DC: The White Hourse Office of National AIDS Policy 2010 13 July 2010.
9.
go back to reference Centers for Disease Control and Prevention. CDC Fact Sheet: HIV Testing in the United States: CDC 2016. Centers for Disease Control and Prevention. CDC Fact Sheet: HIV Testing in the United States: CDC 2016.
10.
go back to reference Paltiel A, Walensky R, Schackman B, Seage G, Mercincavage L, Weinstein M, et al. Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs. Ann Intern Med. 2006;145(11):797–806.CrossRefPubMed Paltiel A, Walensky R, Schackman B, Seage G, Mercincavage L, Weinstein M, et al. Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs. Ann Intern Med. 2006;145(11):797–806.CrossRefPubMed
11.
go back to reference Günthard H, Saag M, Benson C, del Rio C, Eron J, Gallant J, et al. Antiretroviral drugs for treatment and prevention of HIV infection in adults. JAMA. 2016;316(2):191–210.CrossRefPubMedPubMedCentral Günthard H, Saag M, Benson C, del Rio C, Eron J, Gallant J, et al. Antiretroviral drugs for treatment and prevention of HIV infection in adults. JAMA. 2016;316(2):191–210.CrossRefPubMedPubMedCentral
12.
go back to reference McCormack S, Dunn D, Desai M, Dolling D, Gafos M, Gilson R, et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet. 2016;387(10013):53–60.CrossRefPubMedPubMedCentral McCormack S, Dunn D, Desai M, Dolling D, Gafos M, Gilson R, et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet. 2016;387(10013):53–60.CrossRefPubMedPubMedCentral
13.
go back to reference Molina J, Capitant C, Spire B, Pialoux G, Cotte L, Charreau I, et al. On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection. N Engl J Med. 2015;373:2237–46.CrossRefPubMed Molina J, Capitant C, Spire B, Pialoux G, Cotte L, Charreau I, et al. On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection. N Engl J Med. 2015;373:2237–46.CrossRefPubMed
14.
go back to reference Evans E, Li L, Min J, Huang D, Urada D, Liu L, et al. Mortality among individuals accessing pharmacological treatment for opioid dependence in California, 2006–10. Addiction. 2015;110(6):996–1005.CrossRefPubMedPubMedCentral Evans E, Li L, Min J, Huang D, Urada D, Liu L, et al. Mortality among individuals accessing pharmacological treatment for opioid dependence in California, 2006–10. Addiction. 2015;110(6):996–1005.CrossRefPubMedPubMedCentral
15.
go back to reference Aspinall E, Nambiar D, Goldberg D, Hickman M, Weir A, Van Velzen E, et al. Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis. Int J Epidemiol. 2014;18(11):2144–55. Aspinall E, Nambiar D, Goldberg D, Hickman M, Weir A, Van Velzen E, et al. Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis. Int J Epidemiol. 2014;18(11):2144–55.
16.
go back to reference Centers for Disease Control and Prevention. Cases of HIV infection and AIDS in urban and rural areas of the United States, 2006. Atlanta: Centers for Disease Control and Prevention; 2008. Centers for Disease Control and Prevention. Cases of HIV infection and AIDS in urban and rural areas of the United States, 2006. Atlanta: Centers for Disease Control and Prevention; 2008.
17.
go back to reference Centers for Disease Control and Prevention. CDC Fact Sheet: Today’s HIV/AIDS Epidemic: CDC (2016). Centers for Disease Control and Prevention. CDC Fact Sheet: Today’s HIV/AIDS Epidemic: CDC (2016).
18.
go back to reference Centers for Disease Control and Prevention. HIV Surveillance Report, 2014: Center for Disease Control and Prevention (2015). Centers for Disease Control and Prevention. HIV Surveillance Report, 2014: Center for Disease Control and Prevention (2015).
19.
go back to reference Public Health – Seattle & King County. HIV/AIDS Quarterly Surveillance Report. Seattle, WA (2016). Public Health – Seattle & King County. HIV/AIDS Quarterly Surveillance Report. Seattle, WA (2016).
21.
go back to reference Centers for Disease Control and Prevention. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—United States and 6 dependent areas—2013. Atlanta, GA: Centers for Disease Control and Prevention 2015 2015 Contract No.: 2. Centers for Disease Control and Prevention. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—United States and 6 dependent areas—2013. Atlanta, GA: Centers for Disease Control and Prevention 2015 2015 Contract No.: 2.
25.
go back to reference HIV/AIDS Epidemiology Unit—Public Health—& King County. HIV/AIDS Epidemiology Report 2016–2017. Accessed April 25, 2018. HIV/AIDS Epidemiology Unit—Public Health—& King County. HIV/AIDS Epidemiology Report 2016–2017. Accessed April 25, 2018.
26.
go back to reference Florida Department of Health. HIV/AIDS Surveillance 2016. Accessed April 25, 2018. Florida Department of Health. HIV/AIDS Surveillance 2016. Accessed April 25, 2018.
27.
go back to reference Maryland Department of Health. Baltimore Metro HIV Annual Epidemiological Profile. 2017. Accessed April 25, 2018. Maryland Department of Health. Baltimore Metro HIV Annual Epidemiological Profile. 2017. Accessed April 25, 2018.
28.
go back to reference New York City Department of Health and Mental Hygiene. HIV Surveillance Annual Report 2015–2016. Accessed April 25, 2018. New York City Department of Health and Mental Hygiene. HIV Surveillance Annual Report 2015–2016. Accessed April 25, 2018.
29.
go back to reference Los Angeles County Department of Health. 2015 Annual HIV/STD Surveillance Report 2017. Accessed April 25, 2018. Los Angeles County Department of Health. 2015 Annual HIV/STD Surveillance Report 2017. Accessed April 25, 2018.
32.
go back to reference Lehman J, Carr M, Nichol A, Ruisanchez A, Knight D, Langford A, et al. Prevalence and public health implications of state laws that criminalize potential HIV exposure in the United States. AIDS Behav. 2014;18(6):997–1006.CrossRefPubMedPubMedCentral Lehman J, Carr M, Nichol A, Ruisanchez A, Knight D, Langford A, et al. Prevalence and public health implications of state laws that criminalize potential HIV exposure in the United States. AIDS Behav. 2014;18(6):997–1006.CrossRefPubMedPubMedCentral
33.
go back to reference Galletly C, Lazzarini Z. Charges for criminal exposure to HIV and aggravated prostitution filed in the Nashville, Tennessee Prosecutorial Region 2000–2010. AIDS Behav. 2013;17(8):2624–36.CrossRefPubMedPubMedCentral Galletly C, Lazzarini Z. Charges for criminal exposure to HIV and aggravated prostitution filed in the Nashville, Tennessee Prosecutorial Region 2000–2010. AIDS Behav. 2013;17(8):2624–36.CrossRefPubMedPubMedCentral
34.
go back to reference Lazzarini Z, Galletly C, Mykhalovskiy E, Harsono D, O’Keefe E, Singer M, et al. Criminalization of HIV transmission and exposure: research and policy agenda. Am J Public Health. 2013;103(8):1350–3.CrossRefPubMedPubMedCentral Lazzarini Z, Galletly C, Mykhalovskiy E, Harsono D, O’Keefe E, Singer M, et al. Criminalization of HIV transmission and exposure: research and policy agenda. Am J Public Health. 2013;103(8):1350–3.CrossRefPubMedPubMedCentral
35.
go back to reference Global Commission on Drug Policy. The War on Drugs and HIV/AIDS: How the Criminalization of drug use fuels the global pandemic. Geneva, Switzerland: Global Commission on Drug Policy. 2012. Global Commission on Drug Policy. The War on Drugs and HIV/AIDS: How the Criminalization of drug use fuels the global pandemic. Geneva, Switzerland: Global Commission on Drug Policy. 2012.
36.
go back to reference Miller A. ‘Needle exchanges’ still left out of state’s anti-HIV fight. The Pulse. 2016. Miller A. ‘Needle exchanges’ still left out of state’s anti-HIV fight. The Pulse. 2016.
38.
go back to reference Centers for Disease Control and Prevention. HIV Prevention Funding Allocations at CDC-Funded State and Local Health Departments, 2010. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. 2012. Centers for Disease Control and Prevention. HIV Prevention Funding Allocations at CDC-Funded State and Local Health Departments, 2010. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. 2012.
40.
go back to reference Leibowitz A, Mendes A, Desmond K. Public funding of HIV/AIDS prevention, treatment and support in California. J Acquir Immune Defic Syndr. 2011;58(1):e11–6.CrossRefPubMedPubMedCentral Leibowitz A, Mendes A, Desmond K. Public funding of HIV/AIDS prevention, treatment and support in California. J Acquir Immune Defic Syndr. 2011;58(1):e11–6.CrossRefPubMedPubMedCentral
48.
go back to reference Lucin S. Georgia’s Fulton County opens first PrEP clinic in south. HIV Equal online. 2016 4 February 2016. Lucin S. Georgia’s Fulton County opens first PrEP clinic in south. HIV Equal online. 2016 4 February 2016.
53.
go back to reference Centers for Disease Control and Prevention. CDC Fact Sheet: Trends in U.S. HIV Diagnoses, 2005–2014: CDC. 2016. Centers for Disease Control and Prevention. CDC Fact Sheet: Trends in U.S. HIV Diagnoses, 2005–2014: CDC. 2016.
54.
go back to reference Tempalski B, Pouget E, Cleland C, Brady J, Cooper H, Hall H, et al. Trends in the population prevalence of people who inject drugs in US metropolitan areas 1992-2007. PLoS ONE. 2013;8(6):e64789.CrossRefPubMedPubMedCentral Tempalski B, Pouget E, Cleland C, Brady J, Cooper H, Hall H, et al. Trends in the population prevalence of people who inject drugs in US metropolitan areas 1992-2007. PLoS ONE. 2013;8(6):e64789.CrossRefPubMedPubMedCentral
55.
go back to reference Grey J, Bernstein K, Sullivan P, Purcell D, Chesson H, Gift T, et al. Estimating the Population Sizes of Men Who Have Sex With Men in US States and Counties Using Data From the American Community Survey. JMIR Public Health Surv. 2016;2(1):e14.CrossRef Grey J, Bernstein K, Sullivan P, Purcell D, Chesson H, Gift T, et al. Estimating the Population Sizes of Men Who Have Sex With Men in US States and Counties Using Data From the American Community Survey. JMIR Public Health Surv. 2016;2(1):e14.CrossRef
58.
go back to reference Centers for Disease Control and Prevention. Syringe Exchange Programs—United States, 2008, Morbidity and Mortality Weekly Report (Atlanta, GA: US Centers for Disease Control Contract No.: 45. Centers for Disease Control and Prevention. Syringe Exchange Programs—United States, 2008, Morbidity and Mortality Weekly Report (Atlanta, GA: US Centers for Disease Control Contract No.: 45.
60.
go back to reference Auslen M. Gov. Rick Scott signes needle exchange, rape kit bills into law. Florida: Miami Herald; 2016. Auslen M. Gov. Rick Scott signes needle exchange, rape kit bills into law. Florida: Miami Herald; 2016.
61.
go back to reference Klas M. Legislature approves Miami-Dade needle exchange, sends bill to governor. Miami Herald. 2016. Klas M. Legislature approves Miami-Dade needle exchange, sends bill to governor. Miami Herald. 2016.
62.
go back to reference Driscoll A. Fighting HIV in Miami, one dirty needle at a time. Miami Herald. 2016. Accessed August 10, 2016. Driscoll A. Fighting HIV in Miami, one dirty needle at a time. Miami Herald. 2016. Accessed August 10, 2016.
66.
go back to reference Ashton C, Peterson N, Souchek J, Menke T, Yu H-J, Eigenbrodt M, et al. Geographic variations in utilization rates in Veterans Affairs hospitals and clinics. N Engl J Med. 1999;340:32–9.CrossRefPubMed Ashton C, Peterson N, Souchek J, Menke T, Yu H-J, Eigenbrodt M, et al. Geographic variations in utilization rates in Veterans Affairs hospitals and clinics. N Engl J Med. 1999;340:32–9.CrossRefPubMed
67.
go back to reference The Congress of the United States. Geographic Variation in Health Care Spending: Congressional Budget Office2008 Contract No.: 2978. The Congress of the United States. Geographic Variation in Health Care Spending: Congressional Budget Office2008 Contract No.: 2978.
68.
70.
go back to reference Anderson S, Cherutich P, Kilonzo N, Cremin I, Fecht D, Kimanga D, et al. Maximising the effect of combination HIV prevention through prioritisation of the people and places in greatest need: a modelling study. Lancet. 2014;384(9939):249–56.CrossRefPubMed Anderson S, Cherutich P, Kilonzo N, Cremin I, Fecht D, Kimanga D, et al. Maximising the effect of combination HIV prevention through prioritisation of the people and places in greatest need: a modelling study. Lancet. 2014;384(9939):249–56.CrossRefPubMed
71.
go back to reference Skarbinski J, Rosenberg E, Paz-Bailey G, Hall I, Rose C, Viall A, et al. Human immunodeficiency virus transmission at each step of the care continuum in the United States. JAMA Intern Med. 2015;175(4):588–96.CrossRefPubMed Skarbinski J, Rosenberg E, Paz-Bailey G, Hall I, Rose C, Viall A, et al. Human immunodeficiency virus transmission at each step of the care continuum in the United States. JAMA Intern Med. 2015;175(4):588–96.CrossRefPubMed
72.
go back to reference O’Byrne P, Bryan A, Roy M. HIV criminal prosecutions and public health: an examination of the empirical research. Med Humanit. 2013;39:85–90.CrossRefPubMed O’Byrne P, Bryan A, Roy M. HIV criminal prosecutions and public health: an examination of the empirical research. Med Humanit. 2013;39:85–90.CrossRefPubMed
73.
go back to reference Bini E, Kritz S, Brown L, Robinson J, Alderson D, Rotrosen J. Barriers to providing health services for HIV/AIDS, hepatitis C virus infection and sexually transmitted infections in substance abuse treatment programs. J Addict Dis. 2011;30(2):98–109.CrossRefPubMedPubMedCentral Bini E, Kritz S, Brown L, Robinson J, Alderson D, Rotrosen J. Barriers to providing health services for HIV/AIDS, hepatitis C virus infection and sexually transmitted infections in substance abuse treatment programs. J Addict Dis. 2011;30(2):98–109.CrossRefPubMedPubMedCentral
74.
go back to reference Allen S, Ruiz M, Jones J, Turner M. Legal space for syringe exchage programs in hot spots of injection drug use-related crime. Harm Reduct J. 2016;13:16.CrossRefPubMedPubMedCentral Allen S, Ruiz M, Jones J, Turner M. Legal space for syringe exchage programs in hot spots of injection drug use-related crime. Harm Reduct J. 2016;13:16.CrossRefPubMedPubMedCentral
76.
go back to reference Tookes H, Kral A, Wenger L, Cardenas G, Martinez A, Sherman R, et al. A comparison of syringe disposal practices among injection drug users in a city with versus a city without needle and syringe programs. Drug Alcohol Depend. 2012;123(1–3):255–9.CrossRefPubMed Tookes H, Kral A, Wenger L, Cardenas G, Martinez A, Sherman R, et al. A comparison of syringe disposal practices among injection drug users in a city with versus a city without needle and syringe programs. Drug Alcohol Depend. 2012;123(1–3):255–9.CrossRefPubMed
77.
go back to reference Des Jarlais D, Arasteh K, McKnight C, Hagan H, Perlman D, Semaan S. Associations between herpes simplex virus type 2 and HCV with HIV among injecting drug users in New York City: the current imporantance of sexual transmission of HIV. Am J Public Health. 2011;101(7):1277–83.CrossRefPubMedPubMedCentral Des Jarlais D, Arasteh K, McKnight C, Hagan H, Perlman D, Semaan S. Associations between herpes simplex virus type 2 and HCV with HIV among injecting drug users in New York City: the current imporantance of sexual transmission of HIV. Am J Public Health. 2011;101(7):1277–83.CrossRefPubMedPubMedCentral
78.
go back to reference Congressional Research Services. The Ryan White HIV/AIDS Program: Overview and Impact of the Affordable Care Act. Washington, DC: Congressional Research Services; 2016. Congressional Research Services. The Ryan White HIV/AIDS Program: Overview and Impact of the Affordable Care Act. Washington, DC: Congressional Research Services; 2016.
79.
go back to reference Leibowitz A, Brynes K, Wynn A, Farrell K. HIV tests and new diagnoses declined after California budget cuts, but reallocating funds helped reduce impact. Health Aff (Millwood). 2014;33(3):418–26.CrossRefPubMedPubMedCentral Leibowitz A, Brynes K, Wynn A, Farrell K. HIV tests and new diagnoses declined after California budget cuts, but reallocating funds helped reduce impact. Health Aff (Millwood). 2014;33(3):418–26.CrossRefPubMedPubMedCentral
80.
go back to reference Cheever L, Lubinksi C, Horberg M, Steinberg J. Ensuring access to treatment for HIV infection. Clin Infect Dis. 2007;45(Supplement 4):S266–74.CrossRefPubMed Cheever L, Lubinksi C, Horberg M, Steinberg J. Ensuring access to treatment for HIV infection. Clin Infect Dis. 2007;45(Supplement 4):S266–74.CrossRefPubMed
81.
go back to reference Long E, Mandalia R, Mandalia S, Alistar S, Beck E, Brandeau M. Expanded HIV testing in low-prevalence, high-income countries: a cost-effectiveness analysis for the United Kingdom. PLoS ONE. 2014;9(4):e95735.CrossRefPubMedPubMedCentral Long E, Mandalia R, Mandalia S, Alistar S, Beck E, Brandeau M. Expanded HIV testing in low-prevalence, high-income countries: a cost-effectiveness analysis for the United Kingdom. PLoS ONE. 2014;9(4):e95735.CrossRefPubMedPubMedCentral
82.
go back to reference Day T. The big consequences of small biases: a simulation of peer review. Res Policy. 2015;44(6):1266–70.CrossRef Day T. The big consequences of small biases: a simulation of peer review. Res Policy. 2015;44(6):1266–70.CrossRef
83.
go back to reference Murray D, Morris D, Lavoie C, Leavitt P, MacIsaac H, Masson M, et al. Bias in research grant evaluation has dire consequences for small universities. PLoS ONE. 2016;11(6):e0155876.CrossRefPubMedPubMedCentral Murray D, Morris D, Lavoie C, Leavitt P, MacIsaac H, Masson M, et al. Bias in research grant evaluation has dire consequences for small universities. PLoS ONE. 2016;11(6):e0155876.CrossRefPubMedPubMedCentral
85.
go back to reference Nosyk B, Krebs E, Eyawo O, Min J, Barrios R, Montaner J. Cost-effectiveness analysis along the continuum of HIV care: how can we optimize the effect of HIV treatment as prevention programs? Curr HIV/AIDS Rep. 2014;11(4):468–78.CrossRefPubMed Nosyk B, Krebs E, Eyawo O, Min J, Barrios R, Montaner J. Cost-effectiveness analysis along the continuum of HIV care: how can we optimize the effect of HIV treatment as prevention programs? Curr HIV/AIDS Rep. 2014;11(4):468–78.CrossRefPubMed
86.
go back to reference Brown C, Curran G, Palinkas L, Aarons G, Wells K, Jones L, et al. An overview of research and evaluation designs for dissemination and implementation. Annu Rev Public Health. 2017;38:1–22.CrossRefPubMedPubMedCentral Brown C, Curran G, Palinkas L, Aarons G, Wells K, Jones L, et al. An overview of research and evaluation designs for dissemination and implementation. Annu Rev Public Health. 2017;38:1–22.CrossRefPubMedPubMedCentral
87.
go back to reference Baral S, Logie C, Grosso A, Wirtz A, Beyrer C. Modified social ecological model: a tool to guide the assessment of the risks and risk contexts of HIV epidemics. BMC Public Health. 2013;13:482.CrossRefPubMedPubMedCentral Baral S, Logie C, Grosso A, Wirtz A, Beyrer C. Modified social ecological model: a tool to guide the assessment of the risks and risk contexts of HIV epidemics. BMC Public Health. 2013;13:482.CrossRefPubMedPubMedCentral
88.
go back to reference New York State Department of Health. 2015 Blueprint: For achieving the goal set forth by Governor Cuomo to end the epidemic in New York State by the end of 2020. Albany, NY, 2014. New York State Department of Health. 2015 Blueprint: For achieving the goal set forth by Governor Cuomo to end the epidemic in New York State by the end of 2020. Albany, NY, 2014.
89.
go back to reference Office of Infectious Disease Washington State Department of Health. Integrated HIV Prevention and Care Plan 2017–2021. Washington: Department of Health 2016 October 2016. Office of Infectious Disease Washington State Department of Health. Integrated HIV Prevention and Care Plan 2017–2021. Washington: Department of Health 2016 October 2016.
90.
go back to reference National Alliance of State & Territorial AIDS Directors. 2016 Annual Report: NASTAD2016. National Alliance of State & Territorial AIDS Directors. 2016 Annual Report: NASTAD2016.
91.
go back to reference HIV Resource Tracking for HIV Prevention R & D Working Group. HIV Prevention Research & Development Investments, 2000–2015. New York, USA, 2016. HIV Resource Tracking for HIV Prevention R & D Working Group. HIV Prevention Research & Development Investments, 2000–2015. New York, USA, 2016.
92.
go back to reference Funders Concerned About AIDS. Philanthropic support to address HIV/AIDS in 2015. Washington, DC, 2016. Funders Concerned About AIDS. Philanthropic support to address HIV/AIDS in 2015. Washington, DC, 2016.
93.
go back to reference Centers for Disease Control and Prevention. Cost of HIV Treatment. Atlanta (GA) 2016 8 February 2016. Centers for Disease Control and Prevention. Cost of HIV Treatment. Atlanta (GA) 2016 8 February 2016.
94.
go back to reference Emanuel E. How can the United States spend its health care dollars better? JAMA. 2016;316(24):2604–6.CrossRefPubMed Emanuel E. How can the United States spend its health care dollars better? JAMA. 2016;316(24):2604–6.CrossRefPubMed
95.
go back to reference Dieleman J, Baral R, Birger M, Bui A, Bulchis A, Chapin A, et al. US spending on personal health care and public health, 1996–2013. JAMA. 2016;316(24):2627–46.CrossRefPubMedPubMedCentral Dieleman J, Baral R, Birger M, Bui A, Bulchis A, Chapin A, et al. US spending on personal health care and public health, 1996–2013. JAMA. 2016;316(24):2627–46.CrossRefPubMedPubMedCentral
96.
go back to reference Berry S, Yehia B, Cheever L, Hauck H, Korthuis T, Mathews C, et al. Healthcare coverage for HIV provider visits before and after implementation of the Affordable Care Act. Clin Infectious Dis. 2016;63(3):387–95.CrossRef Berry S, Yehia B, Cheever L, Hauck H, Korthuis T, Mathews C, et al. Healthcare coverage for HIV provider visits before and after implementation of the Affordable Care Act. Clin Infectious Dis. 2016;63(3):387–95.CrossRef
Metadata
Title
Building the Case for Localized Approaches to HIV: Structural Conditions and Health System Capacity to Address the HIV/AIDS Epidemic in Six US Cities
Authors
D. Panagiotoglou
M. Olding
B. Enns
D. J. Feaster
C. del Rio
L. R. Metsch
R. M. Granich
S. A. Strathdee
B. D. L. Marshall
M. R. Golden
S. Shoptaw
B. R. Schackman
B. Nosyk
the Localized HIV Modeling Study Group
Publication date
01-09-2018
Publisher
Springer US
Published in
AIDS and Behavior / Issue 9/2018
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-018-2166-6

Other articles of this Issue 9/2018

AIDS and Behavior 9/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine